Reunanen et al. identify compounds that block levodopa-degrading enzymes, offering a potential boost to Parkinson’s treatment.

Sometimes, you need to know how much restriction enzyme is required to cut a specific amount of a certain plasmid within a given time. Here is the calculation tool you have been looking for!

To use VEGFC therapeutically, we need a way to deliver it. I’m not sure nanoparticles are the answer, but we have to start somewhere. We also have a few more revolutionary ideas beyond what we present here: https://doi.org/10.1101/2025.04.23.649697